Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313385382> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4313385382 endingPage "214.20" @default.
- W4313385382 startingPage "214.20" @default.
- W4313385382 abstract "Abstract The immune system recognizes and eliminates malignant cells, and maintains an intricate balance between immune activation and cancer. Historically, spontaneous tumor regression has been observed in some patients experiencing acute microbial infections. Building upon this, it was discovered that repeated subcutaneous injection of novel immunotherapies called Site-Specific Immunomodulators (SSIs), derived from killed bacteria known to cause infection in a particular organ or tissue, may be effective at treating cancer growing in the same site. We hypothesize that SSIs stimulate the body’s immune system to reverse immune suppression and dysfunction in the tumor microenvironment, enabling effective anti-cancer immune responses. To test this hypothesis, we evaluated the efficacy of a lung-specific SSI, QBKPN, in preclinical lung cancer models. Repeated subcutaneous administration of QBKPN significantly reduced lung tumor burden at day 16 post-inoculation (p<0.0001) in the Lewis Lung Carcinoma model, improving median survival by 10 days (p<0.005). Similar results were obtained using the aggressive and poorly-immunogenic B16 lung cancer model. Anticancer efficacy was associated with site-specific infiltration of newly recruited monocytes and neutrophils to the lung and mobilization of antigen presenting cells in the lung-draining lymph node. These data complement the positive results from our compassionate use clinical data, and provide strong evidence that SSIs may improve therapeutic outcomes for cancer patients. QBKPN is currently studied in a Phase 2a clinical trial of non-small cell lung cancer in collaboration with the BC Cancer Agency (Trial NCT02256852)." @default.
- W4313385382 created "2023-01-06" @default.
- W4313385382 creator A5002187849 @default.
- W4313385382 creator A5004830770 @default.
- W4313385382 creator A5006058922 @default.
- W4313385382 creator A5006323417 @default.
- W4313385382 creator A5011692563 @default.
- W4313385382 creator A5013649393 @default.
- W4313385382 creator A5054875793 @default.
- W4313385382 creator A5070012515 @default.
- W4313385382 creator A5087654744 @default.
- W4313385382 date "2016-05-01" @default.
- W4313385382 modified "2023-09-26" @default.
- W4313385382 title "Site-Specific Immunomodulators (SSIs) are novel immunotherapies for cancer" @default.
- W4313385382 doi "https://doi.org/10.4049/jimmunol.196.supp.214.20" @default.
- W4313385382 hasPublicationYear "2016" @default.
- W4313385382 type Work @default.
- W4313385382 citedByCount "0" @default.
- W4313385382 crossrefType "journal-article" @default.
- W4313385382 hasAuthorship W4313385382A5002187849 @default.
- W4313385382 hasAuthorship W4313385382A5004830770 @default.
- W4313385382 hasAuthorship W4313385382A5006058922 @default.
- W4313385382 hasAuthorship W4313385382A5006323417 @default.
- W4313385382 hasAuthorship W4313385382A5011692563 @default.
- W4313385382 hasAuthorship W4313385382A5013649393 @default.
- W4313385382 hasAuthorship W4313385382A5054875793 @default.
- W4313385382 hasAuthorship W4313385382A5070012515 @default.
- W4313385382 hasAuthorship W4313385382A5087654744 @default.
- W4313385382 hasConcept C121608353 @default.
- W4313385382 hasConcept C126322002 @default.
- W4313385382 hasConcept C143998085 @default.
- W4313385382 hasConcept C203014093 @default.
- W4313385382 hasConcept C2776107976 @default.
- W4313385382 hasConcept C2776256026 @default.
- W4313385382 hasConcept C2777701055 @default.
- W4313385382 hasConcept C2777714996 @default.
- W4313385382 hasConcept C2780849966 @default.
- W4313385382 hasConcept C502942594 @default.
- W4313385382 hasConcept C535046627 @default.
- W4313385382 hasConcept C71924100 @default.
- W4313385382 hasConcept C8891405 @default.
- W4313385382 hasConceptScore W4313385382C121608353 @default.
- W4313385382 hasConceptScore W4313385382C126322002 @default.
- W4313385382 hasConceptScore W4313385382C143998085 @default.
- W4313385382 hasConceptScore W4313385382C203014093 @default.
- W4313385382 hasConceptScore W4313385382C2776107976 @default.
- W4313385382 hasConceptScore W4313385382C2776256026 @default.
- W4313385382 hasConceptScore W4313385382C2777701055 @default.
- W4313385382 hasConceptScore W4313385382C2777714996 @default.
- W4313385382 hasConceptScore W4313385382C2780849966 @default.
- W4313385382 hasConceptScore W4313385382C502942594 @default.
- W4313385382 hasConceptScore W4313385382C535046627 @default.
- W4313385382 hasConceptScore W4313385382C71924100 @default.
- W4313385382 hasConceptScore W4313385382C8891405 @default.
- W4313385382 hasIssue "1_Supplement" @default.
- W4313385382 hasLocation W43133853821 @default.
- W4313385382 hasOpenAccess W4313385382 @default.
- W4313385382 hasPrimaryLocation W43133853821 @default.
- W4313385382 hasRelatedWork W2990680987 @default.
- W4313385382 hasRelatedWork W3025154575 @default.
- W4313385382 hasRelatedWork W3028822667 @default.
- W4313385382 hasRelatedWork W3108853735 @default.
- W4313385382 hasRelatedWork W3125366473 @default.
- W4313385382 hasRelatedWork W4224222365 @default.
- W4313385382 hasRelatedWork W4286629873 @default.
- W4313385382 hasRelatedWork W4291367166 @default.
- W4313385382 hasRelatedWork W4304979265 @default.
- W4313385382 hasRelatedWork W4312075079 @default.
- W4313385382 hasVolume "196" @default.
- W4313385382 isParatext "false" @default.
- W4313385382 isRetracted "false" @default.
- W4313385382 workType "article" @default.